Consequences of Human Inactivity

Sponsor
Rigshospitalet, Denmark (Other)
Overall Status
Completed
CT.gov ID
NCT01828229
Collaborator
(none)
50
1
5
76.9
0.6

Study Details

Study Description

Brief Summary

Epidemiological studies as well as both longitudinal animal and human inactivity studies indicate that low physical activity is associated with the pathophysiology of type 2 diabetes mellitus (T2DM) and obesity, and recently it has been estimated that physical inactivity (worldwide) causes 7% of the burden of disease related to e.g. T2DM. Physical inactivity, a high energy dietary intake, and T2DM are also associated with dementia, depression, and impaired cognitive function. It is critical that we understand how inactivity alters body composition, glucose and lipid metabolism, and cognitive function, if normal physical activity can prevent these changes, and if there are any differences between sexes.

The present protocol is divided in several in several sub-studies:
  1. To test whether and how a physically inactive lifestyle will influence body composition, glucose and lipid metabolism, and cognitive function.

  2. To test whether normal physical activity can prevent the deleterious effect of a physically inactive lifestyle despite a high-caloric intake.

  3. To test whether the influence of a physically inactive lifestyle combined with a high-caloric intake differs between sexes.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: female inactivity and hypercaloric diet
  • Behavioral: inactivity
  • Behavioral: inactivity and hypercaloric diet
  • Behavioral: normal activity and hypercaloric diet
  • Behavioral: inactivity and iso-caloric diet
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Consequences of Human Inactivity
Study Start Date :
Jan 1, 2009
Actual Primary Completion Date :
Jun 1, 2015
Actual Study Completion Date :
Jun 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: female inactivity and hypercaloric diet

inactivity and hypercaloric diet in women for two weeks

Behavioral: female inactivity and hypercaloric diet
female inactivity and hypercaloric diet for 2 weeks

Experimental: inactivity

Inactivity for two weeks

Behavioral: inactivity
inactivity for 2 weeks

Experimental: inactivity and hypercaloric diet

inactivity and hypercaloric diet for two weeks

Behavioral: inactivity and hypercaloric diet
inactivity and hypercaloric diet for 2 weeks

Experimental: normal activity and hypercaloric diet

Normal activity and hypercaloric diet for two weeks

Behavioral: normal activity and hypercaloric diet
normal activity and hypercaloric diet for 2 weeks

Active Comparator: inactivity and iso-caloric diet

inactivity and iso-caloric diet for two weeks

Behavioral: inactivity and iso-caloric diet
inactivity and iso-caloric diet for 2 weeks

Outcome Measures

Primary Outcome Measures

  1. Insulin sensitivity [2 weeks]

    Area under the curve of plasma glucose and insulin levels during an oral glucose tolerance test

Secondary Outcome Measures

  1. visceral adiposity [2 weeks]

    Amount of visceral fat is determined by MRI scans

Other Outcome Measures

  1. Cognitive function [2 weeks]

    Assessed by the Conner's Continuous Performance Test II 2000

  2. aerobic fitness [2 weeks]

    maximal oxygen uptake (VO2max) was measured during an incremental exercise test performed on a cycle ergometer

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Normal physical active

  • Healthy

  • 18-40 y of age

  • Non-smokers

Exclusion Criteria:
  • Pregnancy

  • Diabetes in family

Contacts and Locations

Locations

Site City State Country Postal Code
1 Center og inflammation and metabolism, Rigshospitalet Copenhagen Denmark

Sponsors and Collaborators

  • Rigshospitalet, Denmark

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Anders Rasmussen Rinnov, Administrator, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT01828229
Other Study ID Numbers:
  • H-4-2009-082
First Posted:
Apr 10, 2013
Last Update Posted:
Jun 18, 2015
Last Verified:
Jun 1, 2015
Keywords provided by Anders Rasmussen Rinnov, Administrator, Rigshospitalet, Denmark
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 18, 2015